Skip to main content

Table 3 Clinical ICU course

From: Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients

Characteristics Overall
(N = 51)
Early empiric treatment
(n = 31)
Definitive treatment
(n = 20)
P value
New development of organ failurea
 Shock 30 (58.8) 20 (64.5) 10 (50.0) 0.461
 Renal failure requiring renal replacement therapy 13 (25.5) 6 (19.4) 7 (35.0) 0.356
 Extracorporeal membrane oxygenation 2 (3.9) 2 (6.5) 0 (0.0) 0.674
Outcomes
 ICU mortality 19 (37.3) 13 (41.9) 6 (30.0) 0.573
 Length of stay in ICU (days) 15.0 (6.0–29.0) 18.0 (8.5–30.5) 11.0 (5.0–19.0) 0.162
 Hospital mortality 23 (45.1) 15 (48.4) 8 (40.0) 0.765
 Length of stay in hospital (days) 24.0 (15.5–32.5) 25.0 (16.0–34.5) 20.5 (15.5–32.0) 0.493
  1. Data are presented as number (percentage) or as median (interquartile range)
  2. ICU intensive care units
  3. aTwo patients developed shock and renal failure requiring both renal replacement therapy and extracorporeal membrane oxygenation support. Eight patients developed both shock and renal failure requiring renal replacement therapy